Identification of Potential Biomarkers for Ryanodine Receptor 1 (RYR1) Mutation-Associated Myopathies Using Bioinformatics Approach

<div>KEGG and GO enrichment analyses of DEGs. (a) The result of the biological process, molecular function, and cellular component-associated GO terms. (b–d) The size of the dot showed count number of enriched genes in the biological process, molecular function, and cellular component. (e) The result of KEGG pathway analysis.</div>

Disease Markers

fig2

Figure 2

Figure 2: Identification of Potential Biomarkers for Ryanodine Receptor 1 (RYR1) Mutation-Associated Myopathies Using Bioinformatics Approach 